Just in time for World AIDS Day (Dec. 1) international partners are announcing the first efficacy study for an investigational HIV-1-preventive 'mosaic' vaccine. Janssen Pharmaceutical Companies of Johnson & Johnson are joining forces with The Bill & Melinda Gates Foundation and National Institutes of Health on this study, and they have enlisted the aid of top researchers worldwide to conduct the trial.